Cargando…

Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown

BACKGROUND: Starting March 2020 the Italian Government imposed a lockdown to limit the spread of SARS-CoV-2. During lockdown outpatient visits were limited and telemedicine (TM) was encouraged. METHODS: We retrospectively analyzed data from continuous or flash glucose monitoring systems shared throu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boscari, Federico, Ferretto, Sara, Uliana, Ambra, Avogaro, Angelo, Bruttomesso, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790327/ https://www.ncbi.nlm.nih.gov/pubmed/33414391 http://dx.doi.org/10.1038/s41387-020-00147-8

Ejemplares similares

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy
por: Bonora, Benedetta Maria, et al.
Publicado: (2020)

Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care
por: Boscari, Federico, et al.
Publicado: (2022)

Glycemic control after switching to faster aspart in adults with type 1 diabetes
por: Fadini, G. P., et al.
Publicado: (2022)

Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives
por: Boscari, Federico, et al.
Publicado: (2021)

Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance
por: Boscari, F., et al.
Publicado: (2021)

A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
por: Bruttomesso, Daniela, et al.
Publicado: (2021)

Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period
por: Al-Mutairi, Abrar M., et al.
Publicado: (2023)

Psychological outcomes of evening and night closed‐loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2‐month randomized crossover trial
por: Kropff, J., et al.
Publicado: (2016)

Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents’ perspectives on the use of telemedicine
por: Odeh, Rasha, et al.
Publicado: (2020)

Management of Obese Type 1 Diabetes Mellitus (Double Diabetes) Through Telemedicine During COVID-19 Pandemic Lockdown: A Case Report
por: Gupta, Swar, et al.
Publicado: (2022)

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Ghosh, Amerta, et al.
Publicado: (2020)

Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes
por: Cobelli, Claudio, et al.
Publicado: (2012)

Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic
por: Predieri, Barbara, et al.
Publicado: (2020)

The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia
por: Alharthi, Sahar K., et al.
Publicado: (2021)

Use of telemedicine in obstetrics and gynaecology in Zimbabwe during a lockdown period
por: Moyo, Jephat, et al.
Publicado: (2020)

Telemedicine for Ayurveda consultation: Devising collateral methods during the COVID-19 lockdown impasse
por: Rastogi, Sanjeev, et al.
Publicado: (2022)

TELEMEDICINE AND CARDIOLOGY PHARMACIST FOR SUPPORTING CARDIO-OBSTETRIC PATIENTS DURING COVID-19 LOCKDOWN
por: Yaseen, Israa Fadhil, et al.
Publicado: (2021)

Satisfaction With Telemedicine in Patients With Orthopedic Trauma During the COVID-19 Lockdown: Interview Study
por: Rauer, Thomas, et al.
Publicado: (2022)

Telemedicine use by neurosurgeons due to the COVID-19 related lockdown
por: Gadjradj, Pravesh S., et al.
Publicado: (2021)

Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Vaishya, Raju, et al.
Publicado: (2020)

H(ome)bA1c testing and telemedicine: High satisfaction of people with diabetes for diabetes management during COVID-19 lockdown
por: Kanc, Karin, et al.
Publicado: (2020)

Managing Obesity in Lockdown: Survey of Health Behaviors and Telemedicine
por: Minsky, Noga C., et al.
Publicado: (2021)

Causal relationship between stress and sleep quality and the validity of telemedicine during the COVID-19 lockdown
por: Kuroda, Naoto, et al.
Publicado: (2022)

Telemedicine for housebound older persons during the Covid-19 pandemic
por: Beauchet, Olivier, et al.
Publicado: (2020)

Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic
por: Lee, Joyce M., et al.
Publicado: (2021)

Telemedicine in the Management of Type 1 Diabetes
por: Xu, Timothy, et al.
Publicado: (2018)

Telemedicine and diabetes during the COVID-19 era
por: Papazafiropoulou, Athanasia
Publicado: (2022)

Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial
por: Policarpo, Sara, et al.
Publicado: (2021)

I fear COVID but diabetic foot (DF) is worse: a survey on patients’ perception of a telemedicine service for DF during lockdown
por: Iacopi, Elisabetta, et al.
Publicado: (2021)

How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Efficacy of language assessment in Alzheimer’s disease: comparing in-person examination and telemedicine
por: Vestal, Lindsey, et al.
Publicado: (2006)

Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
por: Scott, Sam N., et al.
Publicado: (2020)

Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis
por: De Groot, Julia, et al.
Publicado: (2021)

Managing diabetes in diabetic patients with COVID: where do we start from?
por: Avogaro, Angelo, et al.
Publicado: (2021)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

COVID-19 lockdown negatively impacted on adherence to denosumab therapy: incidence of non-traumatic fractures and role of telemedicine
por: De Vincentis, S., et al.
Publicado: (2022)

Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia
por: Breton, Marc, et al.
Publicado: (2012)

The Association Between Patient Satisfaction and Mode of Visit (Telemedicine Versus In-Person) in a Large Orthopaedic Practice During the COVID-19 Pandemic Lockdown: A Retrospective Study
por: Bisson, Leslie J., et al.
Publicado: (2021)

Orthopedic Telemedicine Outpatient Practice Diagnoses Set during the First COVID-19 Pandemic Lockdown—Individual Observation
por: Glinkowski, Wojciech Michał
Publicado: (2022)

Telemedicine use during the COVID-19 lockdown is associated with fewer depressive symptoms among physicians in private practice
por: Frajerman, Ariel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a9qmv1l0mgn759u1sr2bdet5gf